title: Peyronie's Disease: Overview and Recent Treatment Advances.
abstract: Peyronie's disease is a chronic condition affecting approximately 3% to 9% of adult males and is associated with significant negative effects on physical and psychosocial well-being and quality of life. Historically, treatment has been limited by a lack of understanding of the pathophysiology. Recent advances have led to the first FDA-approved therapy for the treatment of Peyronie's disease. Evaluation, treatment, and management of patients with this condition, including use of an algorithm and pre-/post-treatment questionnaire, will be discussed.
authors.forename: Jacqueline
authors.initials: J
authors.lastname: Pires
authors.forename: Michelle
authors.initials: M
authors.lastname: Travis
authors.forename: Pamela
authors.initials: P
authors.lastname: Ellsworth
mesh_terms: D000305:Adrenal Cortex Hormones / Q000627:therapeutic use*; D000328:Adult; D004509:Education, Nursing, Continuing; D006801:Humans; D008297:Male; D010411:Penile Induration / Q000175:diagnosis* / Q000188:drug therapy* / Q000451:nursing; D011795:Surveys and Questionnaires; D014700:Verapamil / Q000627:therapeutic use*
chemical_list: D000305:Adrenal Cortex Hormones; D014700:Verapamil